REAL-WORLD CLINICAL OUTCOMES AMONG US VETERANS WITH ORAL FACTOR XA INHIBITOR-RELATED MAJOR BLEEDING TREATED WITH ANDEXANET ALFA OR 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE

被引：0
|
作者：
Sutton, S. Scott [1 ]
Magagnoli, Joe [1 ]
Cummings, Tammy H. [1 ]
Dettling, Terry [2 ]
Hardin, James [3 ]
Lovelace, Belinda [2 ]
机构：
[1] Univ South Carolina, Coll Pharm, Dept Clin Pharm & Outcomes Sci, Columbia, SC 29208 USA
[2] Univ South Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA
[3] Alexion, AstraZeneca Rare Dis, Boston, MA USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E107 / E108
页数：2
相关论文
共 41 条
  • [21] Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis
    Nederpelt, Charlie J.
    Naar, Leon
    Krijnen, Pieta
    le Cessie, Saskia
    Kaafarani, Haytham M. A.
    Huisman, Menno V.
    Velmahos, George C.
    Schipper, Inger B.
    CRITICAL CARE MEDICINE, 2021, 49 (10) : E1025 - E1036
  • [22] Retrospective Analysis of the Real-World Utilization of 4-Factor Prothrombin Complex Concentrate and Plasma in Oral Anticoagulant-Associated Bleeding in US Hospitals
    Refaai, Majed A.
    Bajcic, Paolo
    McNeill, Robert
    Hood, Christopher
    Milling, Truman J.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [23] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [24] Real world utilization of Andexanet alfa in the management of oral factor Xa inhibitor-associated gastrointestinal bleeding
    Brown, Caitlin S.
    Mattson, Alicia E.
    Cabrera, Daniel
    Coelho-Prabhu, Nayantara
    Rabinstein, Alejandro A.
    Dettling, Theresa
    McBane II, Robert D.
    Bellolio, Fernanda
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 73 : 1 - 6
  • [25] Andexanet Alfa Is Associated With Reduced In-hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate Among Patients With Intracranial or Gastrointestinal Bleeding
    Fermann, G.
    Dobesh, P.
    Danese, M.
    Lovelace, B.
    Christoph-Schubel, M.
    Dettling, T.
    Koch, B.
    Coleman, C.
    ANNALS OF EMERGENCY MEDICINE, 2022, 80 (04) : S29 - S29
  • [26] Reply to "Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor-related major bleeding"
    Dobesh, Paul P.
    Fermann, Gregory J.
    Christoph, Mary J.
    Koch, Bruce
    Lesen, Eva
    Chen, Hungta
    Lovelace, Belinda
    Dettling, Theresa
    Danese, Mark
    Ulloa, Julie
    Danese, Sherry
    Coleman, Craig I.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (04)
  • [27] The Clinical Impact of 4-Factor Prothrombin Complex Concentrate on Managing Bleeding in Patients on Direct Oral Anticoagulants
    Donohoe, K.
    Levine, R. L.
    TRANSFUSION, 2015, 55 : 167A - 168A
  • [28] Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study
    Yasaka, Masahiro
    Suzuki, Michiyasu
    Kushimoto, Shigeki
    Kiyonaga, Ayako
    Mangione, Antoinette
    Niwa, Yuki
    Terasaka, Naoki
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 221 - 232
  • [29] Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study
    Masahiro Yasaka
    Michiyasu Suzuki
    Shigeki Kushimoto
    Ayako Kiyonaga
    Antoinette Mangione
    Yuki Niwa
    Naoki Terasaka
    Cardiology and Therapy, 2024, 13 : 221 - 232
  • [30] Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study
    Melanie N. Smith
    Lindsay Deloney
    Cassandra Carter
    Kyle A. Weant
    Evert A. Eriksson
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 250 - 255
12345